Reverse phase protein lysate microarrays, or RPAs, provide an exciting new platform for measuring protein expression levels in a large number of biological samples simultaneously. RPAs, originally introduced by Dr. Emanuel Petricoin of the FDA, and Dr. Lance Liotta of the National Institutes of Health, are essentially large arrays of micro dot-blots that can provide accurate, sensitive and quantitative protein expression data on many samples in a single experiment. The platform’s growing use by researchers worldwide has gained the attention of the scientific community, and we hope the FREE webinar download will provide further insights regarding RPAs and their relevance to your own research.
FREE Webinar Download:
Reverse-Phase Protein Arrays (RPAs) for Biomarker Discovery
Learn from the Experts
Listen and watch as a distinguished panel of scientific innovators and recognized thought leaders present their research using the RPA platform in a variety of applications.
Emanuel F. Petricoin III, Ph.D., Professor, Life Sciences & Company Director, Applied Proteomics & Molecular Medicine, George Mason University
Antonia Holway, Ph.D., Director, Microarray Applications, Aushon BioSystems, Inc.
Reverse Phase Protein Arrays: A Robust and Effective Approach to Functional Proteomics
Gordon B. Mills, M.D., Ph.D., Chair and Professor, Systems Biology, The University of Texas, M.D. Anderson Cancer Center
Mark Sevecka, Ph.D., Post-doctoral Associate at the Whitehead Institute for Biomedical Research